Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18814096 | 0.83 | NLN (0.54) | — | |
| SCHEMBL18814479 | 0.82 | CYP3A4 (0.48) | CYP3A4SLC7A5 | |
| SCHEMBL18814478 | 0.81 | NLN (0.53) | — | |
| SCHEMBL18878716 | 0.80 | HRH3 (0.46) | — | |
| SCHEMBL18804674 | 0.79 | CYP3A4 (0.52) | CYP3A4SLC7A5 | |
| SCHEMBL18814428 | 0.77 | NLN (0.53) | — | |
| SCHEMBL18814480 | 0.76 | CYP3A4 (0.49) | CYP3A4SLC7A5 | |
| SCHEMBL18814427 | 0.76 | NLN (0.52) | — | |
| SCHEMBL19839622 | 0.74 | CYP3A4 (0.47) | CYP3A4SLC7A5 | |
| SCHEMBL12343824 | 0.74 | CYP3A4 (0.58) | CYP3A4SLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3170812-B1 | IMIDAZOLE COMPOUND AND LIPOSOME CONTAINING SAME | FUJIFILM CORP (JP) | 2019-05-29 | — | — | EP | disclosed |
| US-9795566-B2 | Imidazole compound and liposome containing same | FUJIFILM CORPORATION (JP) | 2017-10-24 | — | — | US | disclosed |
| EP-3170812-A1 | IMIDAZOLE COMPOUND AND LIPOSOME CONTAINING SAME | Fujifilm Corporation (JP) | 2017-05-24 | — | — | EP | disclosed |
| US-20170119667-A1 | IMIDAZOLE COMPOUND AND LIPOSOME CONTAINING SAME | FUJIFILM CORPORATION (JP) | 2017-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170119667-A1 | IMIDAZOLE COMPOUND AND LIPOSOME CONTAINING SAME | NPC1L1, LETM1, STOML2 | CYP3A4 2661/4885SLC7A5 76/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.